Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro

American Journal of Gastroenterology

Volumn 105, Issue 10, 2010, Pages 2254-2261

  Di Simone, Nicoletta ^a   Silano, Marco ^b   Castellani, Roberta ^a   Di Nicuolo, Fiorella ^a   D'Alessio, Maria C ^a   Franceschi, Francesco ^a   Tritarelli, Alessandra ^a   Leone, Antonio M ^a   Tersigni, Chiara ^a   Gasbarrini, Giovanni ^a   Silveri, Nicolò G ^a   Caruso, Alessandro ^a   Gasbarrini, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; LIPOCORTIN 5; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; ANTIIDIOTYPIC ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE 2, HUMAN;

APOPTOSIS; ARTICLE; CELIAC DISEASE; CELL DAMAGE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NICK END LABELING; NORMAL HUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST; CELL CULTURE; FLOW CYTOMETRY; IMMUNOLOGY; PATHOLOGY; PREGNANCY;

ANTIBODIES, ANTI-IDIOTYPIC; APOPTOSIS; CELIAC DISEASE; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; PLACENTA; PREGNANCY; TRANSGLUTAMINASES; TROPHOBLASTS;

EID: 77957837224     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.233     Document Type: Article

References (35)

1. Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin andyang of celiac disease. Immunol Rev 2005; 206: 219-31. (Pubitemid 41105173)
2. Sollid LM. Coeliac disease: dissecting a complex Inflammatory disorder.Nat Rev Immunol 2002; 2: 647-55.
3. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association(AGA) Institute technical review on the diagnosis and management ofceliac disease. Gastroenterology 2006; 131: 1981-2002.
4. Green PH. Where are all those patients with celiac disease? Am J Gastroenterol 2007; 102: 1461-3.
5. Jabri B, Sollid LM. Mechanisms of disease: immunopathogenesis of celiacdisease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 516-25.
6. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357: 1731-43.
7. Fasano A, Catassi C. Current approaches to diagnosis and treatment ofceliac disease: an evolving spectrum. Gastroenterology 2001; 120: 636-51. (Pubitemid 32171637)
8. Green PH, Fleischauer AT, Bhagat G et al. Risk of malignancy in patientswith celiac disease. Am J Med 2003; 115: 191-5. (Pubitemid 37338143)
9. Ciacci C, Cirillo M, Auriemma G et al. Celiac disease and pregnancyoutcome. Am J Gastroenterol 1996; 91: 718-22.
10. Nørgård B, Fonager K, Sørensen HT et al. Birth outcomes of women withceliac disease: a nationwide historical cohort study. Am J Gastroenterol 1999; 94: 2435-40.
11. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk ofadverse fetal outcome: a population-based cohort study. Gastroenterology 2005; 129: 454-63. (Pubitemid 41096633)
12. Gasbarrini A, Torre ES, Trivellini C et al. Recurrent spontaneous abortionand intrauterine fetal growth retardation as symptoms of coeliac disease.Lancet 2000; 356: 399-400. (Pubitemid 30487500)
13. Tata LJ, Card TR, Logan RF et al. Fertility and pregnancy-related events inwomen with celiac disease: a population-based cohort study. Gastroenterology 2005; 128: 849-55.
14. O'Keeffe J, Mills K, Jackson J et al. T cell proliferation, MHC class IIrestriction and cytokine products of gliadin-stimulated peripheral bloodmononuclear cells. Clin Exp Immunol 1999; 117: 269-76. (Pubitemid 29343597)
15. Martinelli P, Troncone R, Paparo F et al. Coeliac disease and unfavourableoutcome of pregnancy. Gut 2000; 46: 332-5.
16. Sher KS, Mayberry JF. Female fertility, obstetric and gynaecological historyin celiac disease. A case control study. Digestion 1994; 55: 243-6.
17. Hadziselimovic F, Geneto R, Buser M. Celiac disease, pregnancy, smallfor gestational age: role of extravillous trophoblast. Fetal Pediatr Pathol 2007; 26: 125-34. (Pubitemid 47450904)
18. Helige C, Ahammer H, Hammer A et al. Trophoblastic invasion in vitroand in vivo: similarities and differences. Hum Reprod 2008; 23: 2282-91.
19. Barone MV, Caputo I, Ribecco MT et al. Humoral immune response totissue transglutaminase is related to epithelial cell proliferation in celiacdisease. Gastroenterology 2007; 132: 1245-53. (Pubitemid 46627567)
20. Cervio E, Volta U, Verri M et al. Sera of patients with celiac disease andneurologic disorders evoke a mitochondrial-dependent apoptosis in vitro.Gastroenterology 2007; 133: 195-206. (Pubitemid 47031138)
21. Di Simone N, Raschi E, Testoni C et al. Pathogenic role of anti-beta2-glycoprotein I antibodies in antiphospholipid associated fetal loss:characterisation of beta 2-glycoprotein I binding to trophoblast cells andfunctional effects of anti-beta 2-glycoprotein I antibodies in vitro.Ann Rheum Dis 2005; 64: 462-7. (Pubitemid 40283060)
22. Kliman HJ, Nestler JE, Sermasi E et al. Purification, characterization andin vitro differentiation of cytotrophoblasts from human term placentae.Endocrinology 1986; 118: 1567-82. (Pubitemid 16078536)
23. Di Simone N, Meroni PL, Del Papa N et al. Antiphospholipid antibodies affecttrophoblast gonadotropin secretion and invasiveness by binding directly andthrough adhered b2-glycoprotein I. Arthritis Rheum 2000; 43: 140-51. (Pubitemid 30368223)
24. Adler RR, Ng AK, Rote NS. Monoclonal antiphosphatidylserine antibodyinhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995; 53: 905-10.
25. Esposito C, Paparo F, Caputo I et al. Anti-tissue transglutaminase antibodiesfrom coeliac patients inhibit transglutaminase activity both in vitro andin situ. Gut 2002; 51: 177-81. (Pubitemid 34791442)
26. Krupicková S, Tucková L, Flegelová Z et al. Identification of commonepitopes on gliadin, enterocytes, and calreticulin recognised by antigliadinantibodies of patients with coeliac disease. Gut 1999; 44: 168-73.
27. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminaseas the autoantigen of celiac disease. Nat Med 1997; 3: 797-801. (Pubitemid 27298728)
28. Esposito C, Caputo I, Troncone R. New therapeutic strategies for coeliacdisease: tissue transglutaminase as a target. Curr Med Chem 2007; 14: 2572-80. (Pubitemid 350018470)
29. Robinson NJ, Glazier JD, Greenwood SL et al. Tissue transglutaminaseexpression and activity in placenta. Placenta 2006; 27: 148-57.
30. Mix E, Goertsches R, Zett UK. Immunoglobulins\basic considerations.J Neurol 2006; 253: V9-17.
31. Robinson NJ, Baker PN, Jones CJ et al. A role for tissue transglutaminasein stabilization of membrane-cytoskeletal particles shed from the humanplacenta. Biol Reprod 2007; 77: 648-57.
32. Maiuri L, Ciacci C, Ricciardelli I et al. Unexpected role of surface transglutaminasetype II in celiac disease. Gastroenterology 2005; 129: 1400-13. (Pubitemid 41597382)
33. Anjum N, Baker PN, Robinson NJ et al. Maternal celiac disease autoantibodiesbind directly to syncytiotrophoblast and inhibit placental tissuetransglutaminase activity. Reprod Biol Endocrinol 2009; 19: 16.
34. Di Niro R, Ziller F, Florian F et al. Construction of miniantibodies forthe in vivo study of human autoimmune diseases in animal models. BMCBiotechnol 2007; 7: 46. (Pubitemid 47354874)
35. Gianfrani C, Auricchio S, Troncone R. Adaptive and innate immuneresponses in celiac disease. Immunol Lett 2005; 99: 141-5. (Pubitemid 40966029)